Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-11-050874
Filing Date
2011-09-01
Accepted
2011-08-31 20:26:40
Documents
7
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 v233941_10qa.htm 10-Q/A 23827
  Complete submission text file 0001144204-11-050874.txt   1075624

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT rcll-20110630.xml EX-101.INS 101576
3 XBRL TAXONOMY EXTENSION SCHEMA rcll-20110630.xsd EX-101.SCH 14143
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rcll-20110630_cal.xml EX-101.CAL 23884
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rcll-20110630_def.xml EX-101.DEF 62314
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcll-20110630_lab.xml EX-101.LAB 134311
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcll-20110630_pre.xml EX-101.PRE 80344
Mailing Address 2 BRIAR LANE NATICK, MA 01760
Business Address 2 BRIAR LANE NATICK, MA 01760 508-647-4065
RegenoCELL Therapeutics, Inc. (Filer) CIK: 0001221749 (see all company filings)

EIN.: 000000000
Type: 10-Q/A | Act: 34 | File No.: 000-50639 | Film No.: 111069536
SIC: 2834 Pharmaceutical Preparations